Healthcare Sales & Marketing Network News: Massachusetts General Hospital

Searching News Database: Massachusetts General Hospital

HSMN NewsFeed - 11 Jun 2026
Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2026
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2024
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2024
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Nov 2023
BD Names Dr. Ronald Silverman as Chief Medical Officer
Devices Diagnostics Personnel

HSMN NewsFeed - 13 Nov 2023
SmartCardia names Dr. Jag Singh as a Principal Advisor
Devices Cardiology Monitoring Personnel

HSMN NewsFeed - 20 Sep 2023
Day Zero Diagnostics Announces Completion of $16M Financing Round
Diagnostics Venture Capital

HSMN NewsFeed - 7 Jun 2023
Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever(TM) System and Malibu Aspiration Catheter(TM) System
Devices Interventional FDA

HSMN NewsFeed - 31 Jan 2023
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
Devices Neurology Reimbursement

HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Devices Dermatology FDA

HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA

HSMN NewsFeed - 8 Nov 2022
Sensorium Therapeutics Closes $30 Million Series A to Transform Mental Health Treatment with Nature-Inspired Psychoactive Medicines
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Oct 2022
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2022
Marengo Therapeutics Appoints Ke Liu, MD, PhD, and Bruce Chabner, MD, to Key Leadership Roles, Strengthening Marengo's Development Team and Supporting Translation to the Clinic
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Dec 2021
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 29 Sep 2021
TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
Devices FDA

HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 18 Aug 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Devices Surgery Venture Capital

HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 4 Aug 2021
Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(TM) Endovascular System
Devices Interventional

HSMN NewsFeed - 26 Jul 2021
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Jun 2021
Palatin Announces New Additions to Its Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2020
BrainStorm Announces NurOwn(R) Expanded Access Program
Regenerative Medicine Neurology Product Launch

HSMN NewsFeed - 2 Dec 2020
HiberCell Bolsters Leadership Team with Appointment of Joseph Talamo as Chief Financial Officer and Promotion of Ari Nowacek, M.D., Ph.D., to Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Regenerative Medicine Neurology

HSMN NewsFeed - 17 Nov 2020
BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study
Regenerative Medicine Neurology

HSMN NewsFeed - 3 Sep 2020
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
Devices Dermatology Venture Capital

HSMN NewsFeed - 17 Apr 2020
Hoth Therapeutics Announces Additions to its Board of Directors
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Mar 2020
FDA Clears Next Generation HydroPICC from Access Vascular
Devices FDA

HSMN NewsFeed - 14 Feb 2020
Kleo Pharmaceuticals Elects CEO Doug Manion, MD, FCRP (C), New Chairman of the Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Feb 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2019
EarlySense Appoints New Senior Vice President of Customer Success to Support Rapid Adoption of Contact-free Continuous Monitoring
Devices Monitoring Personnel

HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2019
ProTom Receives U.S. FDA 510(k) Clearance for Its Radiance 330(R) Single Room Proton Therapy System
Devices Oncology FDA

HSMN NewsFeed - 18 Sep 2019
Biohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor, Selected For Platform Trial Collaboration At Massachusetts General Hospital's Healey & AMG Center For Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Jul 2019
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 May 2019
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)
Diagnostics Oncology

HSMN NewsFeed - 2 Apr 2019
CASI Pharmaceuticals Announces the Appointment of Wei-Wu He, Ph.D., Executive Chairman, to the Role of Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Feb 2019
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
Devices Dermatology Litigation

HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA

HSMN NewsFeed - 14 Nov 2018
Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Oct 2018
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
Diagnostics Venture Capital

HSMN NewsFeed - 20 Sep 2018
Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Devices Dermatology FDA

HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Sep 2018
Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Sep 2018
Biohaven Appoints Bob Repella to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology

HSMN NewsFeed - 24 Jul 2018
Biohaven Receives FDA May Proceed Letter And Initiates Phase 2/3 Clinical Trial Of Trigriluzole (BHV-4157) In Alzheimer's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals

HSMN NewsFeed - 8 Jun 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2018
Torque Appoints John Hohneker, MD, to Board of Directors and Marcela Maus, MD, PhD, to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Jan 2018
ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
Devices Cardiology

HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Dec 2017
Biohaven Enrolls First Patient In Pivotal Trial Of Trigriluzole In Patients With Obsessive-Compulsive Disorder
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Nov 2017
FDA Clearance For Perspectum Diagnostics' LiverMultiScan(TM) Means More Patients Can Benefit From Access To State-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders
Diagnostics Radiology FDA

HSMN NewsFeed - 16 Nov 2017
Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Oct 2017
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology

HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Sep 2017
NCCN Guidelines to Include Categories of Preference
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 8 Sep 2017
Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2017
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Aug 2017
Biohaven Appoints Julia P. Gregory to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 31 Jul 2017
Biohaven Initiates Second Pivotal Phase 3 Clinical Trial of Oral CGRP Antagonist for the Acute Treatment of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jul 2017
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology

HSMN NewsFeed - 19 Jul 2017
NCCN Guidelines and NCCN Templates to be Integrated into ION Solutions' IntelliDoseTxM Treatment Management Module
Devices Oncology

HSMN NewsFeed - 18 Jul 2017
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology

HSMN NewsFeed - 6 Jul 2017
Biohaven's BHV-5000 Receives Orphan Drug Designation from the FDA in Rett Syndrome
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Jun 2017
Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Jun 2017
NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Devices Oncology Radiology

HSMN NewsFeed - 9 Jun 2017
Kleo Pharmaceuticals Inc. Appoints Douglas J. Manion M.D. as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2017
Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty" Williams, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2017
BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US
Devices Cardiology Radiology Product Launch

HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Mar 2017
Motus GI Appoints Samuel R. Nussbaum, M.D., to Board of Directors
Devices Gastroenterology Oncology Personnel

HSMN NewsFeed - 17 Mar 2017
New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death
Diagnostics Cardiology

HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel

HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Jan 2017
Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Jan 2017
Regeneron Hires Jay Markowitz, M.D., as Senior Vice President of Portfolio Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2016
Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2016
Kleo Pharmaceuticals Inc. Appoints Roy Prieb as Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2016
Kalytera Therapeutics Appoints Dr. Andrew Salzman as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch

HSMN NewsFeed - 23 Feb 2016
TransMedics Announces The World's First Human Liver Transplantation Using The Organ Care System (OCS(TM)) Liver Technology & The Initiation of The OCS(TM) Liver PROTECT U.S. Pivotal Trial
Devices Surgery

HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2016
Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 14 Dec 2015
X4 Pharmaceuticals Unveils Development Strategy for CXCR4 Inhibitor Pipeline in Cancer Supported by $37.5 million Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 23 Oct 2015
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold(TM)
Devices Neurosurgery

HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Sep 2015
Zafgen Announces Transition of Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 10 Aug 2015
Editas Medicine Raises $120 Million to Advance Genome Editing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 14 May 2015
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
Devices Neurosurgery

HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2015
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
Devices Neurosurgery Neurology

HSMN NewsFeed - 10 Feb 2015
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Devices Interventional FDA

HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
Devices Neurology Personnel

HSMN NewsFeed - 30 Jan 2015
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2014
NinePoint Medical Appoints Christopher von Jako, Ph.D., to Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 19 Nov 2014
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT(R) System Data
Devices Interventional

HSMN NewsFeed - 3 Sep 2014
GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution
Devices Radiology Oncology FDA

HSMN NewsFeed - 26 Aug 2014
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2014
Lysosomal Therapeutics Inc. Receives $4.8 Million in Seed Funding
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2014
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
Devices Personnel

HSMN NewsFeed - 25 Mar 2014
BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial
Regenerative Medicine Neurology

HSMN NewsFeed - 20 Mar 2014
NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE(TM) Imaging System
Devices Venture Capital

HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 17 Feb 2014
CoStim Pharmaceuticals, Inc. Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jan 2014
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
Oncology Personnel

HSMN NewsFeed - 13 Jan 2014
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 6 Jan 2014
Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 9 Dec 2013
InVivo Therapeutics Announces Promotions in Technical Operations
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 14 Nov 2013
Jeffrey Paley, MD, Joins Retrophin Inc.’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2013
Loxo Oncology Raises $33 Million in Series A Financing to Fund Development of Small Molecule Oncology Drugs
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 Sep 2013
InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO
Devices Neurosurgery Personnel

HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2013
Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection
Devices Interventional FDA

HSMN NewsFeed - 13 Aug 2013
Quantel's Solutis Granted FDA Clearance
Devices Ophthalmology FDA

HSMN NewsFeed - 31 Jul 2013
Masimo Announces Eight of Top 10 U.S. Hospitals Now Use Masimo SET(R) Pulse Oximetry Technology Hospital-Wide
Devices Monitoring

HSMN NewsFeed - 23 May 2013
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2013
Kaleidoscope Medical Secures Series A Funding
Devices Venture Capital

HSMN NewsFeed - 4 Apr 2013
InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
Devices Neurosurgery

HSMN NewsFeed - 26 Mar 2013
U.S. Food and Drug Administration Approves Full Expansion of BioControl Medical’s INOVATE-HF Study of the CardioFit(R)
Devices Cardiology FDA

HSMN NewsFeed - 28 Feb 2013
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
Devices Neurology FDA

HSMN NewsFeed - 19 Feb 2013
Curis Appoints Ali Fattaey, Ph.D. as President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Feb 2013
Paragonix Technologies, Inc., Announces Clearance of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the Paragonix Sherpa(TM) Cardiac Transport System
Devices Cardiology FDA

HSMN NewsFeed - 30 Jan 2013
Mercantile Court in Spain Rules in ZELTIQ(R) Aesthetics Patent Infringement Lawsuit Against Clinipro
Devices Litigation

HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 22 Jan 2013
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
Devices Oncology

HSMN NewsFeed - 10 Jan 2013
New Study Shows Masimo Noninvasive & Continuous Total Hemoglobin (SpHb(R)) Monitoring Significantly Reduces Blood Transfusions and Costs in High Blood Loss Surgery
Devices Monitoring Surgery

HSMN NewsFeed - 18 Dec 2012
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 14 Dec 2012
InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 8 Oct 2012
AngioDynamics to Acquire Vortex Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Oct 2012
Given Imaging Acquires Assets of SmartPill Corporation
Devices Gastroenterology Acquisitions

HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2012
InVivo Therapeutics Appoints Brian Hess as Interim Chief Science Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Sep 2012
InVivo Therapeutics Announces Business Updates
Devices Neurology

HSMN NewsFeed - 24 Jul 2012
Infinity Announces New Addition to Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2012
Titan Medical Inc. Announces Addition of Dr. Dennis L. Fowler, MD, MPH as Development Consultant
Devices Personnel

HSMN NewsFeed - 30 May 2012
Former Stryker Executive Robert Housler Jr. Joins InVivo Therapeutics as Vice President of Business Development
Devices Personnel

HSMN NewsFeed - 22 May 2012
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Apr 2012
Statement by Dr. Eugen Hug, Chief Medical Officer of ProCure Treatment Centers, Regarding the University of North Carolina Study Comparing Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer
Devices Oncology

HSMN NewsFeed - 4 Apr 2012
OvaScience Secures $37 Million in Series B Financing
Regenerative Medicine Venture Capital Personnel

HSMN NewsFeed - 2 Apr 2012
Boston Scientific Launches Innovative Device Used to Prevent Stone Migration in Urologic Procedures
Devices Urology

HSMN NewsFeed - 21 Mar 2012
Seattle Genetics Appoints Dr. Nancy Simonian to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Feb 2012
Stryker’s 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development
Devices Personnel

HSMN NewsFeed - 25 Jan 2012
ZELTIQ(R) Initiates Patent Infringement Lawsuit Against Clinipro
Devices Litigation

HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 12 Jan 2012
RaySearch Laboratories: RayStation(R) 2.5 released
Devices Oncology

HSMN NewsFeed - 5 Jan 2012
NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
Devices FDA

HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Sep 2011
FDA Approves New Indications for Prolia(R) (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Sep 2011
MAKO Surgical Corp. Introduces MAKOplasty(R) Total Hip Arthroplasty
Devices Orthopaedic

HSMN NewsFeed - 12 Sep 2011
InVivo Therapeutics Promotes Lauren Mitarotondo to Vice President, Operations as InVivo Prepares for Human Studies
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Sep 2011
iPierian Appoints Nancy Stagliano as CEO; Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals

HSMN NewsFeed - 24 Aug 2011
Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market
Devices Monitoring

HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology

HSMN NewsFeed - 25 Jul 2011
First Patient Enrolled in Lutonix Drug-Coated Balloon Pivotal Trial
Devices Interventional

HSMN NewsFeed - 15 Jul 2011
ZIOPHARM Oncology Appoints Hagop Youssoufian, M.Sc., M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2011
Bovine Carotid Artery (BCA) For Hemodialysis Access: 3-Year Prospective, Randomized Clinical Study at Massachusetts General Hospital Confirms Superiority of Artegraft to Cuffed ePTFE
Devices

HSMN NewsFeed - 6 Jun 2011
AVI BioPharma Names Ed Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2011
Internationally Renowned Radiation Oncologist and Proton Therapy Researcher Joins ProCure Treatment Centers
Devices Oncology Personnel

HSMN NewsFeed - 13 Apr 2011
TARIS Closes $18.3 Million Series B Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 12 Apr 2011
AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Feb 2011
ZELTIQ(TM) Starts 2011 by Strengthening Management Team
Devices Personnel

HSMN NewsFeed - 17 Feb 2011
InVivo Therapeutics Appoints Phil Pereira Director of Manufacturing
Devices Personnel

HSMN NewsFeed - 26 Jan 2011
Long-Term European Data Released for SUPERA(R) Stent from IDEV Technologies
Devices Interventional

HSMN NewsFeed - 12 Jan 2011
RaySearch Laboratories: RaySearch Establishes North American Sales Organization
Devices Radiology Personnel

HSMN NewsFeed - 5 Jan 2011
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
Oncology

HSMN NewsFeed - 9 Dec 2010
New Multiple Myeloma Treatment Guidelines for Patients Available from NCCN
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Oct 2010
RaySearch Laboratories: Massachusetts General Hospital in Boston Chooses RaySearch’s Treatment Planning System RayStation(R)
Devices Oncology

HSMN NewsFeed - 22 Jul 2010
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Jun 2010
Siemens Launches SIERRA Dose Reduction Initiative in Computed Tomography
Devices Radiology

HSMN NewsFeed - 23 Jun 2010
Biosense Webster Receives FDA Clearances for the CARTOXPRESS Software Module and LASSO(R) NAV Catheter for its CARTO(R) XP System
Devices Cardiology FDA

HSMN NewsFeed - 23 Jun 2010
ARIAD Names Timothy P. Clackson to New Position of President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 May 2010
Medtronic Announces New Data from STOP AF Pivotal Trial
Devices Cardiology

HSMN NewsFeed - 11 May 2010
KCI Appoints Ron Silverman, M.D., FACS, Chief Medical Officer
Devices Wound Care Personnel

HSMN NewsFeed - 22 Apr 2010
Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
Devices Personnel

HSMN NewsFeed - 15 Apr 2010
CE Certification Granted for IBA's 2nd Generation Pencil Beam Scanning Proton Treatment System
Devices Oncology Regulatory

HSMN NewsFeed - 7 Apr 2010
First New Jersey Proton Therapy Center Breaks Ground
Devices Oncology

HSMN NewsFeed - 25 Mar 2010
Proteostasis Therapeutics Announces Additions of Key Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Mar 2010
NCCN Guidelines Expand Their Reach to Japan
Oncology

HSMN NewsFeed - 10 Mar 2010
Sam Donaldson Named Inaugural Chair of NCCN Foundation Board
Oncology Personnel

HSMN NewsFeed - 9 Mar 2010
Varian Medical Systems Names Dr. John Adler as Chief of New Clinical Applications
Devices Oncology Neurosurgery Personnel

HSMN NewsFeed - 26 Feb 2010
SCAI Statement on the CREST Study Findings: Carotid Stenting Is as Safe and Effective as Carotid Surgery in Patients at Risk for Stroke
Devices Interventional Neurology

HSMN NewsFeed - 23 Feb 2010
Financing Closed for First Proton Therapy Center in New Jersey
Devices Oncology

HSMN NewsFeed - 26 Jan 2010
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 6 Jan 2010
T2 BioSystems Appoints Ken Toso Vice President, Product Development
Diagnostics Personnel

HSMN NewsFeed - 16 Dec 2009
Merck Appoints Dr. Michael Rosenblatt As Executive Vice President & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2009
NormOxys Appoints Industry Veteran and Recognized Neuroscience Expert, Martin Tolar, MD, PhD, as Company's CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Nov 2009
GE Healthcare Announces Multi-Center Study To Investigate Performance Of MBIR For Ultra-Low Dose CT Exams
Devices Radiology

HSMN NewsFeed - 25 Nov 2009
QLT announces MGH litigation settlement
Biopharmaceuticals Licensing Litigation Ophthalmology

HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Nov 2009
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 7 Oct 2009
Penumbra, Inc. Enrolls First Patient in the START Clinical Trial to Define Image Guided Patient Selection Criteria for Interventional Acute Ischemic Stroke Treatment
Devices Interventional Radiology Neurosurgery Neurology

HSMN NewsFeed - 2 Oct 2009
Massachusetts General Hospital Selects Elekta as New Vendor for Complete Cancer Treatment Solution
Devices Oncology

HSMN NewsFeed - 9 Sep 2009
Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company's CSO
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2009
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Aug 2009
IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
Devices Interventional

HSMN NewsFeed - 7 Aug 2009
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Jul 2009
Massachusetts General Hospital to install IMRISneuro
Devices Neurosurgery Radiology

HSMN NewsFeed - 25 Mar 2009
Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
Devices Neurology

HSMN NewsFeed - 18 Mar 2009
Harvard Study Favors Cayenne Medical's AperFix Technology for Reconstruction of Torn ACL
Devices Orthopaedic

HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Devices Interventional Cardiology

HSMN NewsFeed - 19 Feb 2009
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Devices Neurology

HSMN NewsFeed - 19 Feb 2009
Small Bone Innovations Receives European Union CE Mark for Its PRECISE SD Distal Volar Radius Plating System
Devices Orthopaedic Regulatory

HSMN NewsFeed - 17 Feb 2009
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jan 2009
Genentech Announces Vice President Appointment in Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Nov 2008
NCCN Updates Guidelines for Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Oct 2008
Concentric Medical Launches Distal Access Catheter
Devices Interventional

HSMN NewsFeed - 17 Oct 2008
T2 Biosystems Raises $10.8 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 12 Sep 2008
PhotoMedex Now Distributing Omnilux Photodynamic Therapy Line by Photo Therapeutics
Devices Dermatology Distribution

HSMN NewsFeed - 12 Sep 2008
Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
Diagnostics Personnel

HSMN NewsFeed - 2 Sep 2008
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Aug 2008
FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jul 2008
EKOS(R) Introduces New EkoSonic(TM) Endovascular System With Rapid Pulse(TM) Modulation Technology - Four Times Faster Than Conventional Catheter-Directed Thrombolysis
Devices Interventional

HSMN NewsFeed - 22 Jul 2008
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
Diagnostics Cardiology FDA

HSMN NewsFeed - 16 Jul 2008
PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jun 2008
iCAD To Acquire Assets of CAD Sciences
Devices Radiology Mergers & Acquisitions

HSMN NewsFeed - 20 Jun 2008
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Jun 2008
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2008
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2008
Northstar Neuroscience Announces Presentation of Long-Term Data of Cortical Stimulation for Depression and Stroke Recovery
Devices Neurosurgery

HSMN NewsFeed - 30 May 2008
NCCN Previews Chemotherapy Order Templates(TM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 8 May 2008
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
Devices Interventional Cardiology

HSMN NewsFeed - 28 Apr 2008
Clinical Data on the Use of Medtronic's Deep Brain Stimulation System for Psychiatric Disorders to Be Presented at International Neurosurgical Meeting
Devices Neurosurgery

HSMN NewsFeed - 24 Apr 2008
Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2008
NCCN Updates Non-Hodgkin's Lymphoma Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Apr 2008
VisEn Medical Raises $5.0 Million in Expanded Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 27 Mar 2008
Oncology Researcher Forecasts Increased Use of Predictive Medicine at NCCN Conference
Diagnostics Oncology

HSMN NewsFeed - 13 Mar 2008
Sequence of Treatments May Induce Clinical Response in Metastatic Renal Cell Carcinoma Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Mar 2008
Novelos Therapeutics Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Feb 2008
Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2008
NCCN Updates Ovarian Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Feb 2008
Boston Scientific Announces Addition to Clinical Sciences Organization
Devices Personnel

HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Feb 2008
Xanodyne Announces Two Senior Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2008
Elekta: Procure Selects IMPAC as Provider of Oncology Information Systems
Devices Oncology

HSMN NewsFeed - 10 Jan 2008
Idera Pharmaceuticals Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Devices Dermatology Venture Capital

HSMN NewsFeed - 3 Jan 2008
T2 Biosystems Appoints John McDonough as CEO
Diagnostics Personnel

HSMN NewsFeed - 20 Dec 2007
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Dec 2007
Harvard University Completes Clinical Study of Pegasus HeartVue 6S System Heart Screening Device
Devices Cardiology

HSMN NewsFeed - 17 Dec 2007
MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 10 Dec 2007
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2007
ARIAD Expands Leadership Team with Three New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2007
Fifty Hospitals Around the World Are Now Using NeuroLogica's CereTom® Portable CT Scanner
Devices Neurology Radiology

HSMN NewsFeed - 26 Nov 2007
NCCN Updates Pancreatic Adenocarcinoma Guidelines
Oncology

HSMN NewsFeed - 15 Nov 2007
NCCN Receives Major Grant for Anti-Cancer Drug Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Nov 2007
Toshiba Announces Its Fourth Generation Contrast-Free Technique -- Time and Space Angiography (TSA)
Devices Radiology

HSMN NewsFeed - 8 Nov 2007
NeuroLogica's CereTom(R) Portable CT Scanner Used During Surgery on Conjoined Twins
Devices Radiology Neurology

HSMN NewsFeed - 7 Nov 2007
Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress Echo is Well-tolerated and as Effective as Nuclear Perfusion Imaging for Evaluating Chest Pain Patients at Risk for Heart Attack
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Oct 2007
VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
VisEn Medical Raises $7 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 23 Oct 2007
NCCN Updates Central Nervous System Cancers Guidelines
Devices Oncology

HSMN NewsFeed - 23 Oct 2007
NCCN Updates Multiple Myeloma Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Oct 2007
NCCN Updates Non-Small Cell Lung Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2007
JNCCN Named as Reference by CMS for Off-Label Coverage Decisions
Oncology

HSMN NewsFeed - 1 Oct 2007
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 25 Sep 2007
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
Devices Orthopaedic

HSMN NewsFeed - 25 Sep 2007
ProCure Treatment Centers Teams with Forte Automation Systems to Enhance Proton Therapy for Cancer Patients
Devices Oncology

HSMN NewsFeed - 24 Sep 2007
Cook Medical Receives FDA Approval to Begin U.S. Phase I Clinical Trial for Cook Zenith(R) Dissection Endovascular System
Devices Interventional FDA

HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
Children's Hospital & Research Center Oakland Brings Portable CT Scanning to Pediatric Patients
Devices Radiology Neurology

HSMN NewsFeed - 11 Sep 2007
NCCN Updates Dermatofibrosarcoma Protuberans Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Sep 2007
NCCN Updates Hepatobiliary Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Sep 2007
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Aug 2007
AngioDynamics Launches a Single Needle Radio Frequency Electrode for Multiple Small Lesion Ablations
Devices Interventional

HSMN NewsFeed - 1 Aug 2007
NCCN Updates Kidney Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Aug 2007
NCCN Updates Cervical Cancer Guidelines
Devices Oncology

HSMN NewsFeed - 20 Jul 2007
CMS Selected by ProCure to Provide Comprehensive Treatment Planning Solution for New Proton Therapy Center in Oklahoma
Devices Oncology

HSMN NewsFeed - 20 Jul 2007
CMS, Inc. Collaborates with Still River Systems for Proton Beam Therapy
Devices Oncology

HSMN NewsFeed - 19 Jul 2007
Advanced Image Enhancement (AIE) Announces Licensing Agreement with Hologic
Devices Radiology Oncology Licensing

HSMN NewsFeed - 18 Jul 2007
CardiacAssist, Inc. Announces 1000th TandemHeart System Procedure
Devices Cardiology

HSMN NewsFeed - 28 Jun 2007
Avicena to Advance Huntington's Disease Clinical Program into Phase III
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jun 2007
Dr. Lee Swanstrom, a Surgeon at The Oregon Clinic, has Performed the First Transgastric NOTES Gall Bladder Surgery in the US
Devices Surgery

HSMN NewsFeed - 20 Jun 2007
NCCN Updates Non-Hodgkin's Lymphoma Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jun 2007
Toshiba to Sponsor Harvard Medical School Course in Virtual Colonoscopy
Devices Radiology Gastroenterology

HSMN NewsFeed - 18 Jun 2007
Bio-Matrix Scientific Group, Inc.'s Dr. Geoffrey O'Neill Sees Promise in New Studies for Producing Embryonic-Like Stem Cells from Skin Cells
Regenerative Medicine

HSMN NewsFeed - 18 Jun 2007
Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
NCCN Updates Thyroid Carcinoma Guidelines
Oncology

HSMN NewsFeed - 23 May 2007
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
Biopharmaceuticals

HSMN NewsFeed - 22 May 2007
NCCN Updates Esophageal and Gastric Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2007
NCCN Updates Head and Neck Cancers Guidelines
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 22 May 2007
CytRx Names Shi Chung Ng, Ph.D., Senior Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2007
Biomet Introduces First Vitamin E Stabilized Highly Crosslinked Polyethylene Products to the Market
Devices Orthopaedic

HSMN NewsFeed - 11 May 2007
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2007
Dr. John P. Donoghue Presents on Cyberkinetics' BrainGate Neural Interface System in Plenary Session at the AAN Annual Meeting in Boston
Devices Neurology

HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Biopharmaceuticals Radiology

HSMN NewsFeed - 30 Apr 2007
NCCN Updates Prevention and Treatment of Cancer-Related Infections Guidelines
Oncology

HSMN NewsFeed - 26 Apr 2007
Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board Chaired by Company Co-founder, John L. Gainer, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2007
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
Devices Cardiology

HSMN NewsFeed - 23 Apr 2007
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Apr 2007
QuantRx(R) Biomedical Acquires Majority Interest in FluoroPharma
Diagnostics Cardiology

HSMN NewsFeed - 16 Apr 2007
Aeris Therapeutics Strengthens Management Team
Devices Drug Delivery Personnel

HSMN NewsFeed - 9 Apr 2007
ProCure Begins Construction on Oklahoma's First Proton Therapy Cancer Treatment Center
Devices Oncology

HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Mar 2007
Robot Spurs Men's Recovery After Surgery, Urologist Says at NCCN Annual Conference
Devices Surgery Oncology

HSMN NewsFeed - 8 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board for Respiratory and Acute Care Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2007
TechniScan Medical Systems Taps Dr. John Klock for Board of Directors
Devices Radiology Personnel

HSMN NewsFeed - 5 Mar 2007
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
Oncology

HSMN NewsFeed - 5 Mar 2007
NeuroLogica Receives Canadian Medical Device License for the CereTom(TM) CT Scanner
Devices Radiology Neuro Regulatory

HSMN NewsFeed - 5 Mar 2007
QLT Settles MEEI Lawsuit With Respect to the '303 Patent
Biopharmaceuticals Ophthalmology Litigation

HSMN NewsFeed - 26 Feb 2007
NCCN Updates Occult Primary Guidelines
Diagnostics Oncology

HSMN NewsFeed - 26 Feb 2007
NCCN Updates Myelodysplastic Syndromes (MDS) Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Feb 2007
Swedish Medical Center Enhances Neuroscience Institute With Portable CT Scanner from NeuroLogica
Devices Radiology Neuro

HSMN NewsFeed - 23 Feb 2007
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
CereTom(TM) Mobile Brain CT Imaging Machine Enabling More Access and Faster Scans at Thomas Jefferson University Hospital
Devices Radiology Neuro

HSMN NewsFeed - 15 Feb 2007
Top Hospitals Use Arctic Sun(R) Device to Chill Patients, Avert Brain Damage
Devices Neurology

HSMN NewsFeed - 13 Feb 2007
NCCN Updates Breast Cancer Risk Reduction Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2007
BioBehavioral Diagnostics Secures $8.5 Million Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 29 Jan 2007
Indianapolis' Methodist Hospital Installs Portable CT Scanner from NeuroLogica
Devices Radiology Neurology

HSMN NewsFeed - 29 Jan 2007
NCCN Updates Prostate Cancer Guidelines
Devices Surgery Oncology

HSMN NewsFeed - 29 Jan 2007
NCCN Updates Colon Cancer Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jan 2007
NCCN Updates Non-Small Cell Lung Cancer Guidelines
Devices Radiology Oncology

HSMN NewsFeed - 18 Jan 2007
Candela Secures Exclusive Rights to Develop Tattoo Removal Device for Freedom-2 Tattoos
Devices Dermatology

HSMN NewsFeed - 8 Jan 2007
NCCN Updates Multiple Myeloma Guidelines
Oncology

HSMN NewsFeed - 8 Jan 2007
NCCN Offers HER2 Testing for Breast Cancer Patients(TM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2007
NCCN Updates Antiemesis Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2007
Tyco Announces Nominees to Board of Directors for Tyco Healthcare
Devices Personnel

HSMN NewsFeed - 3 Jan 2007
Cleveland Clinic Sees Neuroimaging Important to Faster ER Diagnosis of Stroke and Brain Trauma
Devices Radiology Neurology

HSMN NewsFeed - 20 Dec 2006
Richard T. Clark Elected Chairman of Merck & Co., Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2006
Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women with Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers
Diagnostics Oncology

HSMN NewsFeed - 14 Dec 2006
Response Biomedical Files for US FDA 510k Market Clearance of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
Diagnostics Cardiology FDA

HSMN NewsFeed - 13 Dec 2006
CoAxia(TM) Announces FDA Approval of Clinical Trial for Its Novel Stroke Treatment in Patients up to 24 Hours After Onset
Devices Neurology Interventional FDA

HSMN NewsFeed - 13 Dec 2006
Lapatinib (Tykerb(R)) to be Evaluated in Early Stage Disease in Adjuvant Breast Cancer Settings Internationally
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Dec 2006
ImmunoCellular Therapeutics Announces Dr. Robert Martuza, Chief of Neurosurgery at Mass. General, Joins Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2006
Celgene Appoints Thomas O. Daniel, M.D. as President of Global Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2006
Epiphany Biosciences Appoints Brian Murphy as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Nov 2006
Vicor Technologies Initiates Clinical Sites for Pivotal Vital Trial; Enrolls First Two Patients; Targets FDA 510(k) Submission in 2008
Devices Monitoring Cardiology

HSMN NewsFeed - 2 Nov 2006
Cohera Medical, Inc. Announces Dr. Doros Platika Elected as Chairman of the Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 31 Oct 2006
CytRx's Arimoclomol Granted Orphan Drug Designation in European Union for Treatment of ALS
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Dennis A. Ausiello To Join Pfizer Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2006
St. Jude Medical Appoints Dr. Mark D. Carlson as Chief Medical Officer and Senior Vice President, Clinical Affairs, for CRM Division
Devices Cardiology Personnel

HSMN NewsFeed - 15 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Communication Device and Wheelchair Control for First Stroke Participant in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 14 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Computer Control for First ALS Patient in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2006
BioMimetic Therapeutics Adds Key Talent to Board of Directors
Devices Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2006
SmartPill Wins 510(k) Release from FDA
Devices Gastroenterology FDA

HSMN NewsFeed - 6 Jul 2006
First Human Implants of Ample Medical's PS3 System(TM)
Devices Interventional Cardiology

HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
Devices Cardiology FDA

HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Devices Ophthalmology Licensing

HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Campbell Rogers, M.D., International Expert in Interventional Cardiology and Vascular Conditions, Named Chief Technology Officer of Cordis Corporation
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 22 May 2006
Aspect Antidepressant Response Index Accurately Predicts Patient Response to SSRI's after One Week on Medication
Devices

HSMN NewsFeed - 16 May 2006
Spirus Medical Announces Formation of Medical Advisory Board
Devices Personnel

HSMN NewsFeed - 15 May 2006
St. Jude Medical Announces FDA Clearance of EnSite(R) System 6 Software for Cardiac Mapping and Navigation
Devices Cardiology FDA

HSMN NewsFeed - 15 May 2006
EntreMed Initiates Combination Phase 2 Clinical Trial With Panzem(R) NCD in Carcinoid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 May 2006
Siemens and Massachusetts General Hospital Develop Prototype 128-Channel MRI System Based on Tim Technology
Devices Radiology

Return to NewsFeed

Additional items found! 175

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 175 additional stories matching:
Massachusetts General Hospital
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!